Tuesday January 19, 2021
In todays report:
American Medical Association Asks Court To Overturn Medical Marijuana Vote In Mississippi
This video is featured content from the followig weedcash.network blogpost
Additionally, because marijuana remains federally illegal, the voter-approved measure would put physicians in “quite the pinch,” it says. “Yet physicians will be expected by their patients to sign off on certifications to receive their supply. Perhaps no liability will lie under state law, but what about federal law?”
In fact, federal courts have ruled that doctors have a First Amendment right to discuss medical cannabis with their patients without risking federal sanction
These are cynical attempts to undermine the democratic process,” Carly Wolf, state policies coordinator for NORML, said. “Legalization opponents have shown time and time again that they cannot succeed in either the court of public opinion or at the ballot box.”
It is regrettable that this organization would go on record in attempting to nullify the vote of a supermajority of Mississippi voters,” he said.
It’s also not especially surprising that these particular groups would join in this legal challenge given their earlier attempts to get voters to reject the reform initiative.
Ultimately, however, nearly 74 percent of Mississippi voters approved the legalization initiative.
It will allow patients with debilitating medical issues to legally obtain marijuana after getting a doctor’s recommendation. It includes 22 qualifying conditions such as cancer, chronic pain and post-traumatic stress disorder, and patients would be allowed to possess up to 2.5 ounces of marijuana per 14-day period.
New York Governor Says Budget Uses Marijuana Revenue For Social Equity, With Details Forthcoming
Senate Majority Leader Andrea Stewart-Cousins (D) said in November that she also anticipates that the reform will advance next year, though she noted that lawmakers will still have to decide on how tax revenue from marijuana sales is distributed.
Cuomo also said that month that the “pressure will be on” to legalize cannabis in the state and lawmakers will approve it “this year” to boost the economy amid the health crisis.
The push to legalize in New York could also be bolstered by the fact that voters in neighboring New Jersey approved a legalization referendum in November.
The THC potency tax is intended to “more accurately capture both the true market value and the potential public health risks associated with the final cannabis product,” the governor’s office said, and it will be applied as follows:
“Cannabis flower/pre-roll/shake products are taxed at a rate of 0.7 cent per milligram of THC content. Cannabis concentrates/oil products are taxed at a rate of 1 cent per milligram of THC content, while cannabis infused/edible products are taxed at a rate of 4 cents per milligram of THC content.”
“Of the THC-based tax, retail surcharge, and any license fees, the first $10 million in FY 2023, $20 million in FY 2024, $30 million in FY 2025, $40 million in FY 2026, and $50 million annually thereafter are directed for social equity purposes, with the remainder directed to the newly established New York State Cannabis Revenue Fund,” it states.
Restrictions on shipment of vaping products could impact hemp industry
According to Kight, sellers of vaping products must comply with:
Registering with the U.S. Attorney General.
Implementing an age-verification system.
Shipping through private companies, such as UPS or DHL, that require a signature upon delivery.
FedEx has already said it won’t ship vaping products.
“A lot of them are doing age verification already,” Kight said. “So I think for some, this is going to be a larger project to take on.”
Meanwhile, there will be fly-by-night companies everywhere, not obeying the law, particularly, I believe, in the CBD space because many state regulators don’t even realize that the products could fall under their regime.”
“For nicotine vaping products, which will get the majority of the enforcement, this is very bad,” he said.
California lab Anresco announced Oct. 28 that no tocopheryl-acetate has been found in tests of over 200 licensed cartridges. Of Ohio’s 17 confirmed cases, 90% are black market THC cart-related, and none are medical cannabis system-related